Cost-Effectiveness of Ribociclib for Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

PURPOSE: Ribociclib has provided significant improvements in progression-free survival (PFS) and overall survival (OS) of postmenopausal patients with hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC). However, given the high cos...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Manag Res
Main Authors: Yang, Jiangping, Han, Jiaqi, Tian, Maolang, Tian, Kun, Liao, Wenjun, Yan, Xi
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751309/
https://ncbi.nlm.nih.gov/pubmed/33364838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S284556
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker